Celcius Launches Rs 500 Million Pharma Logistics Arm

18 Aug 2025 CW Team

In its first phase, the company will invest Rs 500 million to build a dedicated pharma fleet and supporting infrastructure, aiming to generate Rs 1 billion in annual recurring revenue (ARR) from this vertical within 18 months. Of this, Rs 350 million will be used to deploy 100 new reefer vehicles along key pharmaceutical corridors across India, while Rs 100–150 million is earmarked for developing a robust pharma courier system for high-demand urban and semi-urban markets.

To drive this expansion, Celcius will hire 30–40 specialists in pharma logistics, operations, and compliance. Leveraging its advanced tech platform, Celcius+ will provide real-time tracking, continuous temperature monitoring, and AI-enabled route optimisation, ensuring shipments comply with the highest quality standards.

Founder and CEO Swarup Bose said: “With Celcius+, we are expanding capacity while setting new benchmarks for safety, transparency, and operational excellence in pharma logistics. Our investment marks the start of a focused journey to reduce wastage, ensure compliance, and bridge gaps in pharma distribution with technology-driven solutions.”

Celcius+ plans to partner with leading pharmaceutical companies and extend its reach to over 100 cities by the end of 2025. Its services will cover primary and secondary distribution, as well as last-mile pharma courier delivery for high-value products including vaccines, biologics, insulin, and specialty medicines.

The 24-ft reefer fleet will be equipped with advanced telematics, digital lock systems, CCTV surveillance, and 24/7 tracking via a central control tower. This infrastructure is designed to guarantee product integrity and fast response to any disruptions.

Earlier this year, Celcius Logistics raised Rs 2.5 billion in an oversubscribed Series B round to accelerate technology upgrades and network expansion. Currently operating across 600 cities, the company aims to scale to more than 1,000 cities in the coming years, with Celcius+ strengthening its presence in pharmaceutical logistics.

Celcius Logistics, India’s leading tech-driven 3PL and cold supply chain provider, has launched Celcius+, a dedicated vertical for the seamless management of the pharmaceutical supply chain. The new arm is designed to meet the sector’s stringent demands for temperature control, compliance, and real-time visibility, ensuring safe and efficient transport of medicines, vaccines, and other sensitive products.In its first phase, the company will invest Rs 500 million to build a dedicated pharma fleet and supporting infrastructure, aiming to generate Rs 1 billion in annual recurring revenue (ARR) from this vertical within 18 months. Of this, Rs 350 million will be used to deploy 100 new reefer vehicles along key pharmaceutical corridors across India, while Rs 100–150 million is earmarked for developing a robust pharma courier system for high-demand urban and semi-urban markets.To drive this expansion, Celcius will hire 30–40 specialists in pharma logistics, operations, and compliance. Leveraging its advanced tech platform, Celcius+ will provide real-time tracking, continuous temperature monitoring, and AI-enabled route optimisation, ensuring shipments comply with the highest quality standards.Founder and CEO Swarup Bose said: “With Celcius+, we are expanding capacity while setting new benchmarks for safety, transparency, and operational excellence in pharma logistics. Our investment marks the start of a focused journey to reduce wastage, ensure compliance, and bridge gaps in pharma distribution with technology-driven solutions.”Celcius+ plans to partner with leading pharmaceutical companies and extend its reach to over 100 cities by the end of 2025. Its services will cover primary and secondary distribution, as well as last-mile pharma courier delivery for high-value products including vaccines, biologics, insulin, and specialty medicines.The 24-ft reefer fleet will be equipped with advanced telematics, digital lock systems, CCTV surveillance, and 24/7 tracking via a central control tower. This infrastructure is designed to guarantee product integrity and fast response to any disruptions.Earlier this year, Celcius Logistics raised Rs 2.5 billion in an oversubscribed Series B round to accelerate technology upgrades and network expansion. Currently operating across 600 cities, the company aims to scale to more than 1,000 cities in the coming years, with Celcius+ strengthening its presence in pharmaceutical logistics.

Resources

04 Jun 2026

ULCCS Showcases Cooperative Model at UN Symposium

Uralungal Labour Contract Co-operative Society (ULCCS) showcased its community-led development model at the United Nations Headquarters in New York, where it participated as a panellist at the International Symposium on Cooperative Financial Institutions held on 28–29 May 2026.Jointly organised by the United Nations Department of Economic and Social Affairs (UN DESA), the International Cooperative Banking Association (ICBA), and the International Cooperative Alliance (ICA), the symposium was held under the theme ‘Fuelling Inclusive and Equitable Growth’ and brought together policymakers,..

Infrastructure Transport

04 Jun 2026

Delhi Airport to Finalise 20-Year Master Plan

Delhi International Airport Ltd (DIAL) is finalising a 20-year master plan to guide long term infrastructure and operational development at Indira Gandhi International Airport, an official said. The operator expects the plan to reflect changes in the airline industry, shifts in the competitive landscape and evolving infrastructure requirements across terminals, airside and support services. The official said the document is likely to be ready in the next two to two-and-a-half months as the operator moves through planning stages. The plan will be prepared after consultations with airport users ..

Real Estate

04 Jun 2026

Aadhar Housing Finance Targets Rs 500 bn AUM By FY29

Aadhar Housing Finance has set a target to raise its asset under management to Rs 500 billion (bn) by the end of FY29, aiming to achieve this over the next three financial years through an 18-20 per cent loan growth trajectory. The firm focuses on the low-income segment with a ticket size of less than Rs 1.5 million (mn) and has relied on that segment to drive expansion. The company closed FY26 with an AUM of Rs 305.71 bn, reflecting the expansion in recent years, and it reported a net profit rise of 22 per cent to Rs 11.08 bn. Management indicated that gross non-performing assets stood at 1.0..